Skyscape Web Viewer : Physicians' Cancer Chemotherapy Drug Manual : Main Index

View All
gastric cancer
Gavreto
GCB
G-CSF Bladder Cancer Esophageal Cancer Leukemia Lymphoma Soft Tissue Sarcomas Endometrial Cancer Head and Neck Cancer Lung Cancer Osteogenic Sarcoma Thymoma
gefitinib Gefitinib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Lung Cancer Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
GEM-CAP
gemtuzumab Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
gemtuzumab ozogamicin
Gilotrif
gilteritinib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Gilteritinib Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
glasdegib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Glasdegib Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
glofitamab
goserelin Goserelin Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Breast Cancer Prostate Cancer Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
goserelin hydroxyurea
granisetron Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting: Common Regimens for Chemotherapy-Induced Nausea and Vomiting
GVD
gastrointestinal stromal tumor (GIST)
Gazyva
GCP
gemcitabine
Gemzar
Gleevec
GTX
GW572016